Selected article for: "abstract abstract and acute respiratory syndrome"
Author: Brosnahan, Shari B.; Jonkman, Annemijn H.; Kugler, Matthias C.; Munger, John S.; Kaufman, David A.
Title: COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions
  • Cord-id: 0ddeuehn
  • Document date: 2020_9_22
    • ID: 0ddeuehn
    Snippet: The severe acute respiratory syndrome coronavirus-2 emerged as a serious human pathogen in late 2019, causing the disease coronavirus disease 2019 (COVID-19). The most common clinical presentation of severe COVID-19 is acute respiratory failure consistent with the acute respiratory distress syndrome. Airway, lung parenchymal, pulmonary vascular, and respiratory neuromuscular disorders all feature in COVID-19. This article reviews what is known about the effects of severe acute respiratory syndro
    Document: The severe acute respiratory syndrome coronavirus-2 emerged as a serious human pathogen in late 2019, causing the disease coronavirus disease 2019 (COVID-19). The most common clinical presentation of severe COVID-19 is acute respiratory failure consistent with the acute respiratory distress syndrome. Airway, lung parenchymal, pulmonary vascular, and respiratory neuromuscular disorders all feature in COVID-19. This article reviews what is known about the effects of severe acute respiratory syndrome coronavirus-2 infection on different parts of the respiratory system, clues to understanding the underlying biology of respiratory disease, and highlights current and future translation and clinical research questions. GRAPHIC ABSTRACT: A graphic abstract is available for this article.

    Search related documents:
    Co phrase search for related documents
    • abnormal thrombosis and acute disease: 1, 2
    • ace angiotensin and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace angiotensin and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace angiotensin and acute respiratory failure: 1, 2, 3, 4, 5, 6
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute disease: 1, 2, 3, 4
    • ace inhibitor and acute respiratory failure: 1
    • active area and acute ards respiratory distress syndrome: 1
    • active area and acute disease: 1, 2, 3
    • active research and acute ards respiratory distress syndrome: 1, 2, 3
    • active research and acute disease: 1, 2, 3
    • active research area and acute disease: 1